SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 7 — Focused Visit (Care-plan review) — Ernest Shackleton — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientErnest Shackleton
Date of birth1874-02-15
IdentifiersMRN HR-EX001-SYN-TD; SSN (made up) 000-01-7763
Document date1921-09-08
AuthorCormac Ellingsworth-Daly, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Pre-departure review: exercise test and expedition medical plan. [S]

History of Present Illness

Mr. Shackleton returns nine days before his expedition sails, after a symptom-limited exercise test this morning. He has had no chest pain since the stent, has completed 18 sessions of cardiac rehabilitation, and walks briskly every day. The back strain from two weeks ago has settled with heat and acetaminophen, and he has delegated the lifting. He has not smoked for sixteen weeks and takes varenicline. He drinks two drinks at most, on four evenings a week. He takes aspirin, clopidogrel, atorvastatin, ezetimibe, and metoprolol daily. He wants to know what to carry and what to do if his heart gives trouble at sea. [S]

ElementDetail
AnginaNone
Rehabilitation18 sessions completed
BackStrain settled
TobaccoNot smoked for sixteen weeks
AlcoholTwo drinks at most on four evenings a week

Review of Systems

SystemResultFinding
CardiovascularNegativeNo chest pain, palpitations, fainting, or swelling
RespiratoryNegativeNo cough or breathlessness
HematologicNegativeNo bleeding beyond occasional bruises
MusculoskeletalNegativeBack pain gone; no muscle aches

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Aspirin 81 mg delayed-release tablet, one tablet by mouth dailyonce dailyOral route1921-05-12activeS
Atorvastatin 80 mg tablet, one tablet by mouth dailyonce dailyOral route1921-05-12activeS
Metoprolol succinate extended-release 50 mg tablet, one tablet by mouth dailyonce dailyOral route1921-05-12 to 1921-05-26stoppedS
Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue for chest pain, repeat every 5 minutes up to 3 dosesas needed for chest pain, up to 3 dosesSublingual route1921-05-12activeS
Varenicline 1 mg tablet, one tablet by mouth twice a day after a one-week starter titrationtwice a day after titrationOral route1921-05-12activeS
Metoprolol succinate extended-release 100 mg tablet, one tablet by mouth dailyonce dailyOral route1921-05-26activeS
Clopidogrel 75 mg tablet, one tablet by mouth daily for six months after the stent (600 mg loading dose before the procedure)once daily for six monthsOral route1921-07-01activeS
Ezetimibe 10 mg tablet, one tablet by mouth dailyonce dailyOral route1921-07-21activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1921-09-08Body height175cmS
1921-09-08Body weight83kgS
1921-09-08Body mass index (BMI) [Ratio]27.1kg/m2S
1921-09-08Systolic blood pressure120mm[Hg]S
1921-09-08Diastolic blood pressure76mm[Hg]S
1921-09-08Heart rate58/minS
1921-09-08Respiratory rate14/minS
1921-09-08Body temperature36.6CelS
1921-09-08Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1921-09-08Cholesterol [Mass/volume] in Serum or Plasma108mg/dL<=199 mg/dLNormalS
1921-09-08Cholesterol in HDL [Mass/volume] in Serum or Plasma45mg/dL>=40 mg/dLNormalS
1921-09-08Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation44mg/dLBelow 100 for the general population; below 55 is his treatment targetNormalS
1921-09-08Triglyceride [Mass/volume] in Serum or Plasma95mg/dL<=149 mg/dLNormalS
1921-09-08Hemoglobin A1c/Hemoglobin.total in Blood5.7%<=5.6%HighS
1921-09-08Total score [AUDIT-C]3{score}S

Physical Exam

Vital signs recorded on 1921-09-08; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 120/76, pulse 58, weight 83.0 kg, BMI 27.1
CardiovascularRegular rhythm; no murmur; no edema
RespiratoryClear to auscultation bilaterally
BackFull, painless movement

Problems

ProblemClinical statusVerificationCodeProvenance
Chest tightness and breathlessness on exertion for about three months, brought on by stairs, carrying loads, and walking fast in cold wind and relieved within minutes by rest, never at rest; resting ECG normal; cause not yet established at intake; coronary CT angiography and cardiology consultation requestedresolvedconfirmed R07.89S — Synthetic presenting problem anchored to his documented exertional breathlessness; superseded by the diagnosis at the cardiology consultation.
Nicotine dependence, cigarettes: about 25 a day since 16 (about 39 pack-years)activeconfirmed F17.210S — Synthetic modern coding anchored to his documented heavy smoking.
Chronic coronary disease with stable exertional angina: 80% stenosis of the proximal left anterior descending artery with CT-FFR 0.70, mild right coronary artery disease, coronary calcium score 210, and normal left ventricular function; synthetic modern episode linked to his documented exertional illnesses and the coronary atheroma recorded at his deathactiveconfirmed I25.118S — Synthetic modern diagnosis made at the cardiology consultation; Macklin's coronary diagnosis is recorded in CLM-0009 and the alternative theories as R.
Hyperlipidemia: LDL cholesterol 168 mg/dL and HDL 38 mg/dL at intakeactiveconfirmed E78.5S — Synthetic modern risk factor; no historical measurement exists.
Prediabetes: HbA1c 5.9% at intakeactiveconfirmed R73.03S — Synthetic modern risk factor; no historical measurement exists.
Drug-eluting stent in the proximal left anterior descending artery, placed for angina that persisted on medical therapy; dual antiplatelet therapy for six monthsactiveconfirmed Z95.5S — Synthetic status after the modern procedure.
Acute low back strain after lifting crates of stores, without sciatica or red flags; managed without NSAIDs because he takes aspirin and clopidogrel; resolvedresolvedconfirmed S39.012AS — Synthetic acute problem; not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationBlood pressure (target below 130/80 mmHg)Every visitCompleted today120/76 mmHg, at target
ExaminationWeight, BMI, and physical activityEvery visitCompleted today83.0 kg, BMI 27.1, down 3 kg; active daily
ExaminationAngina frequency and Canadian Cardiovascular Society class, nitroglycerin useEvery visitCompleted todayNo angina since the stent
ImagingSymptom-limited exercise ECG before remote, strenuous travelOnce before departure, as agreed at the consultationCompleted today11 minutes (about 12.8 METs); no angina or ischemic changes
ImagingStress imaging, coronary CT angiography, echocardiography, or invasive angiographyOnly for new or worsening symptoms or a change in function despite optimized therapy; no routine surveillanceNot indicatedAsymptomatic; no surveillance imaging
Medication safetyDual antiplatelet therapy: adherence and bleedingEvery visit during dual therapyCompleted todayBoth taken daily; no bleeding; stop date for clopidogrel written on the summary
Medication safetyAdherence review: aspirin (or dual antiplatelet therapy), high-intensity statin, beta-blocker for anginaEvery visitCompleted todayAll taken daily; supply for the voyage arranged
LaboratoryLipid panel4 to 12 weeks after starting or changing lipid therapy, then every 3 to 12 monthsCompleted todayLDL 44 mg/dL on atorvastatin and ezetimibe; at target; next on his return
LaboratoryHbA1c for prediabetesEvery 3 to 6 months while lifestyle change is under way, then yearlyCompleted today5.7%, from 5.9%
Self-managementTobacco use and cessation support (varenicline with counseling)Every visitCompleted todayAbstinent for sixteen weeks
SurveyAlcohol use (AUDIT-C) and brief interventionEach visit until within limitsCompleted todayAUDIT-C 3
ReferralCardiac rehabilitation referralUp to 36 sessionsCompleted today18 sessions completed; home exercise plan for the voyage
SurveyDepression screen (PHQ-2, then PHQ-9 if positive)PeriodicallyUp to datePHQ-2 0 at the preventive visit
Self-managementInfluenza and COVID-19 vaccination reviewYearlyCompleted todayInfluenza vaccine given today; COVID-19 vaccine declined at the preventive visit
Self-managementRemote expedition plan (exercise test, medicines, defibrillator, evacuation, cold stress)Before departureCompleted todaySummary, medicines, defibrillator, satellite link, evacuation plan, and cold-stress advice in place

Goal progress:

Immunizations given today: Influenza vaccine, 1921-1922 season [S]

Guideline basis: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); 2024 ESC Guidelines for the management of chronic coronary syndromes (Vrints C, et al. Eur Heart J 2024;45(36):3415-3537) (2024); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and hyperlipidemia monographs (2026); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021); Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018); Prediabetes and Type 2 Diabetes: Screening (2021)

Follow-up: Review on his return, with lipids and HbA1c. Satellite messages to the clinic and the cardiology team as needed during the expedition. [S]